Results 231 to 240 of about 46,178 (264)

Cerebral amyloid angiopathies

Neuropathology and Applied Neurobiology, 1996
The cerebral amyloid angiopathies comprise a heterogeneous group of disorders that are characterized clinically by ischaemic and/or haemorrhagic strokes, and histologically by deposition of amyloid in the wall of leptomeningeal and cerebral cortical blood vessels. On the basis of the molecular composition of the amyloid, two forms can be distinguished.
F, Coria, I, Rubio
openaire   +2 more sources

Pathogenesis of cerebral amyloid angiopathy

Brain Research Reviews, 2003
Cerebral amyloid angiopathy (CAA) is the result of the deposition of an amyloidogenic protein in cortical and leptomeningeal vessels. The most common type of CAA is caused by amyloid beta-protein (Abeta), which is particularly associated with Alzheimer's disease (AD).
Rensink, A.A.M., Waal, R.M.W. de, Kremer, H.P.H., Verbeek, M.M.   +3 more
openaire   +3 more sources

Ubiquitin in cerebral amyloid angiopathy

Journal of the Neurological Sciences, 1992
Immunohistological findings in cerebral blood vessels of 4 cases with cerebral amyloid angiopathy (CAA) were compared with those of 4 Alzheimer's (AD) cases. A panel of antibodies against 2 neurofilament subunits (BF10 and RT97), a microtubule-associated protein (TAU) and ubiquitin were used.
F F, Cruz-Sanchez, C, Marin, M L, Rossi, A, Cardozo, I, Ferrer, E, Tolosa   +5 more
openaire   +2 more sources

Cerebral amyloid angiopathy in the aged

Journal of Neurology, 1987
Cerebral amyloid angiopathy (CAA) was found in 57% of 123 autopsy brains removed from patients aged 59-101 years. The incidence of CAA increased with age. CAA was seen most frequently in the occipital cortex. Immunohistochemically, amyloid of CAA was positive for amyloid P component and negative for human AA protein and human prealbumin.
M, Yamada, H, Tsukagoshi, E, Otomo, M, Hayakawa   +3 more
openaire   +2 more sources

Cerebral Amyloid Angiopathy

The American Journal of Forensic Medicine and Pathology, 1996
Cerebral amyloid angiopathy (CAA) is a condition characterized by amyloid deposition in cerebral blood vessels. It occurs most frequently in association with clinical Alzheimer's disease but also occurs in some nondemented elderly people. CAA is a cause of spontaneous cerebral hemorrhage and may therefore present as a sudden unexpected death in an ...
openaire   +2 more sources

Cerebral Amyloid Angiopathy in the Elderly

Journal of the American Geriatrics Society, 1981
ABSTRACT: In this study an attempt was made to determine the relationship between cerebral amyloid angiopathy (AA) and other cerebrovascular lesions in the aged. The brains of 128 autopsy patients over 60 years of age were examined by both light and electron microscopy.
openaire   +2 more sources

Cerebral Amyloid Angiopathy

2004
From a clinical perspective, cerebral amyloid angiopathy (CAA) can be defined as amyloid deposition in the cerebral vessels sufficient to cause symptomatic vascular dysfunction. The syndromes associated with CAA have become increasingly well recognized in clinical practice.
openaire   +1 more source

Cerebral amyloid angiopathy-related hemorrhages

Neurological Sciences, 2008
Cerebral amyloid angiopathy (CAA) is defined by the accumulation of amyloid in the walls of small-and medium-sized cerebral arteries. One of the most recognized complications of CAA is spontaneous, often recurrent, intracerebral hemorrhage, usually involving the cortex and/or subcortical white matter ("lobar hemorrhage").
PEZZINI, Alessandro, PADOVANI, Alessandro   +1 more
openaire   +3 more sources

Cerebral amyloid angiopathy and dementia.

Panminerva medica, 2004
Cerebral amyloid angiopathy (CAA) is a fundamental part of the pathology of many disorders causing dementia and/or cerebral haemorrhage. In Alzheimer's disease (AD), CAA is due to the deposition of amyloid alpha protein (Abeta) within the adventitia and media of leptomeningeal and brain parenchymal arteries.
Tian, J., Shi, J., Mann, D. M A
openaire   +2 more sources

Anticoagulation in patients with cerebral amyloid angiopathy.

The Lancet, 2023
A. Shoamanesh
semanticscholar   +1 more source